Cargando…

Dual Antiplatelet Therapy Can Be Discontinued at Three Months after Implantation of Zotarolimus-Eluting Stent in Patients with Coronary Artery Disease

Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention increases the risk of bleeding. We studied the safety and clinical outcomes of switching from DAPT to aspirin monotherapy at 3 months after ZES implantation. We retrospectively evaluated 168 consecutive patients with coronary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wada, Tadashi, Nakahama, Makoto, Toda, Hironobu, Watanabe, Atsuyuki, Hashimoto, Katsushi, Terasaka, Ritsuko, Nakamura, Kazufumi, Yamada, Nobuyuki, Ito, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649238/ https://www.ncbi.nlm.nih.gov/pubmed/23762606 http://dx.doi.org/10.1155/2013/518968

Ejemplares similares

Zotarolimus-eluting stent-induced hypersensitivity pneumonitis
por: Shin, Hong-Won, et al.
Publicado: (2013)

Advances in drug eluting stents – focus on the Endeavor(®) zotarolimus stent
por: Bridges, Jonathan, et al.
Publicado: (2008)

Simultaneous Multi-Vessel Subacute Stent Thromboses in Zotarolimus-Eluting Stents
por: Kim, Yong-Hyun, et al.
Publicado: (2010)

Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost
por: Arat Ozkan, Alev, et al.
Publicado: (2016)

Two Cases of Immediate Stent Fracture after Zotarolimus-Eluting Stent Implantation
por: Lee, Pil Hyung, et al.
Publicado: (2015)

One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients
por: Kandzari, David E., et al.
Publicado: (2020)

Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents
por: Kim, J-S, et al.
Publicado: (2009)

The Resolute™ Integrity Zotarolimus-Eluting Stent in Coronary Artery Disease: A Review
por: Banerjee, Subhash
Publicado: (2013)

Longitudinal deformation of a third generation zotarolimus eluting stent: “The concertina returns!”
por: Panoulas, Vasileios F, et al.
Publicado: (2017)

Comparison of zotarolimus-eluting and sirolimus-eluting coronary stents: a study from the Western Denmark Heart Registry
por: Maeng, Michael, et al.
Publicado: (2012)

Comparison of 12-Month Outcomes with Zotarolimus- and Paclitaxel-Eluting Stents: A Meta-Analysis
por: Loomba, Rohit S., et al.
Publicado: (2011)

Nobori-Biolimus-Eluting Stents versus Resolute Zotarolimus-Eluting Stents in Patients Undergoing Coronary Intervention: A Propensity Score Matching
por: Tantawy, Ayman, et al.
Publicado: (2017)

Elastic stent recoil in coronary total occlusions: Comparison of durable‐polymer zotarolimus eluting stent and ultrathin strut bioabsorbable‐polymer sirolimus eluting stent
por: Improta, Riccardo, et al.
Publicado: (2021)

Very Late Stent Thrombosis 42 Months after Implantation of Sirolimus-Eluting Stent and Discontinuation of Antiplatelet Therapy
por: Sibbing, Dirk, et al.
Publicado: (2009)

Double-vessel very late stent thrombosis following Resolute Onyx zotarolimus eluting stents implantation in an octogenarian
por: Kassimis, George, et al.
Publicado: (2018)

Outcomes of patients treated with the everolimus-eluting stent versus the zotarolimus eluting stent in a consecutive cohort of patients at a tertiary medical center
por: Shammas, Nicolas W, et al.
Publicado: (2012)

Histopathological Comparison among Biolimus, Zotarolimus and Everolimus-Eluting Stents in Porcine Coronary Restenosis Model
por: Lim, Kyung Seob, et al.
Publicado: (2013)

One-year clinical outcomes of patients implanted with a Resolute Onyx™ zotarolimus-eluting stent
por: Tam, Chor Cheung, et al.
Publicado: (2017)

Clinical Impact of Lesion Complexity on 2-Year Outcomes After Zotarolimus-Eluting Stents Implantation
por: Park, Jung-Ho, et al.
Publicado: (2021)

One‐year clinical outcomes of patients treated with polymer‐free amphilimus‐eluting stents or zotarolimus‐eluting stents: A propensity‐score adjusted analysis
por: Rozemeijer, Rik, et al.
Publicado: (2019)

Simultaneous Thrombosis of Two Drug-Eluting Stents After Discontinuation of Dual Antiplatelet Therapy for a Day
por: Chen, Hung Yi
Publicado: (2012)

A Patient with Repeated Catastrophic Multi-Vessel Coronary Spasm after Zotarolimus-Eluting Stent Implantation
por: Rhew, Shi Hyun, et al.
Publicado: (2013)

Effectiveness and Safety of Zotarolimus-Eluting Stent (Resolute™ Integrity) in Patients with Diffuse Long Coronary Artery Disease
por: Park, Keun-Ho, et al.
Publicado: (2019)

Initial Experience With the Next-Generation Resolute Onyx Zotarolimus-Eluting Stent in Symptomatic Intracranial Atherosclerotic Disease
por: Hassan, Ameer E., et al.
Publicado: (2020)

Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: the SUGAR trial
por: Romaguera, Rafael, et al.
Publicado: (2021)

One-year outcomes of polymer-free amphilimus-eluting stents versus durable polymer zotarolimus-eluting stents in patients with diabetes mellitus: a meta-analysis
por: Wang, Hong, et al.
Publicado: (2022)

Comparison of Zotarolimus- and Everolimus-Eluting Coronary Stents: Final 5-Year Report of the RESOLUTE All-Comers Trial
por: Iqbal, Javaid, et al.
Publicado: (2015)

Very Late Thrombosis of a Drug-Eluting Stent After Discontinuation of Dual Antiplatelet Therapy in a Patient Treated With Both Drug-Eluting and Bare-Metal Stents
por: Kim, Sung Soo, et al.
Publicado: (2009)

Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)
por: Thim, Troels, et al.
Publicado: (2012)

Comparison of 9-month angiographic outcomes of Resolute zotarolimus-eluting and everolimus-eluting stents in a real world setting of coronary intervention in Korea
por: Lee, Joo Myung, et al.
Publicado: (2013)

Comparing Stent Thrombosis associated with Zotarolimus Eluting Stents versus Everolimus Eluting Stents at 1 year follow up: a systematic review and meta-analysis of 6 randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2017)

Five-Year Comparative Efficacy of Everolimus-Eluting vs. Resolute Zotarolimus-Eluting Stents in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Koni, Endrin, et al.
Publicado: (2021)

A Case of a Zotarolimus-Eluting Stent Fracture in the Left Anterior Descending Artery in a Patient Undergoing Hemodialysis
por: Cha, In Hye, et al.
Publicado: (2011)

Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: results from the E-Five Registry
por: Jain, Ajay K, et al.
Publicado: (2010)

Comparison of 3-year clinical outcomes between Endeavor Resolute(®) and Resolute Integrity(®) zotarolimus-eluting stents in an Asian population
por: Kim, Yong Hoon, et al.
Publicado: (2020)

Short-term stent coverage of second-generation zotarolimus-eluting durable polymer stents: Onyx one-month optical coherence tomography study
por: Roleder, Tomasz, et al.
Publicado: (2019)

Three‐year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus‐eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus‐eluting stent: A randomized controlled trial
por: Kim, Soo‐Hyun, et al.
Publicado: (2019)

Real-World Safety and Effectiveness Outcomes of a Zotarolimus-Eluting Stent: Final 3-Year Report of the RESOLUTE International Study
por: BELARDI, JORGE A, et al.
Publicado: (2013)

First-generation paclitaxel- vs. second-generation zotarolimus-eluting stents in small coronary arteries: the BASKET-SMALL Pilot Study
por: Jeger, Raban, et al.
Publicado: (2016)

Perioperative management of antiplatelet therapy in patients with drug-eluting stents
por: Dimitrova, G, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lae1g1dlq4hrfd5sdeqfb1t00e